Financial reports
10-K
2023 FY
Annual report
27 Feb 24
10-Q
2023 Q3
Quarterly report
25 Oct 23
10-Q
2023 Q2
Quarterly report
26 Jul 23
10-Q
2023 Q1
Quarterly report
26 Apr 23
10-K
2022 FY
Annual report
9 Feb 23
10-Q
2022 Q3
Quarterly report
26 Oct 22
10-Q
2022 Q2
Quarterly report
27 Jul 22
10-Q
2022 Q1
Quarterly report
27 Apr 22
10-K/A
2021 FY
Annual report (amended)
15 Mar 22
10-K
2021 FY
Annual report
18 Feb 22
Current reports
8-K
Regulation FD Disclosure
26 Feb 24
8-K
Pilgrim’s Pride Reports Fourth Quarter and Year-End 2023 Results
26 Feb 24
8-K
Departure of Directors or Certain Officers
9 Feb 24
8-K
Regulation FD Disclosure
25 Oct 23
8-K
Pilgrim’s Pride Reports Third Quarter 2023 Results with $4.4 Billion in Net Sales and Operating Income of $206.4 Million
25 Oct 23
8-K
Entry into a Material Definitive Agreement
13 Oct 23
8-K
Entry into a Material Definitive Agreement
10 Oct 23
8-K
Other Events
28 Sep 23
8-K
Regulation FD Disclosure
26 Jul 23
8-K
Pilgrim’s Pride Reports Second Quarter 2023 Results with $4.3 Billion in Net Sales and Operating Income of $100.3 Million
26 Jul 23
Registration and prospectus
424B5
Prospectus supplement for primary offering
28 Sep 23
FWP
Free writing prospectus
27 Sep 23
424B5
Prospectus supplement for primary offering
27 Sep 23
424B5
Prospectus supplement for primary offering
5 Apr 23
FWP
Free writing prospectus
4 Apr 23
424B5
Prospectus supplement for primary offering
4 Apr 23
S-3ASR
Automatic shelf registration
22 Mar 23
424B3
Prospectus supplement
19 Jan 23
S-4
Registration of securities issued in business combination transactions
22 Dec 22
S-8
Registration of securities for employees
13 Mar 20
Proxies
DEF 14A
Definitive proxy
1 Apr 24
DEFA14A
Additional proxy soliciting materials
18 Apr 23
PX14A6G
Letter to shareholders
3 Apr 23
DEF 14A
Definitive proxy
27 Mar 23
PRE 14A
Preliminary proxy
17 Mar 23
DEF 14A
Definitive proxy
28 Mar 22
PX14A6G
Letter to shareholders
5 Apr 21
DEF 14A
Definitive proxy
29 Mar 21
PX14A6G
Letter to shareholders
22 Mar 21
PRE 14A
Preliminary proxy
19 Mar 21
Other
EFFECT
Notice of effectiveness
19 Jan 23
CORRESP
Correspondence with SEC
13 Jan 23
UPLOAD
Letter from SEC
11 Jan 23
CORRESP
Correspondence with SEC
22 Dec 22
UPLOAD
Letter from SEC
12 Oct 22
CORRESP
Correspondence with SEC
4 Oct 22
UPLOAD
Letter from SEC
22 Sep 22
NO ACT
No action letter
25 Feb 16
UPLOAD
Letter from SEC
17 Sep 13
CORRESP
Correspondence with SEC
13 Sep 13
Ownership
4
Fabio Sandri
19 Mar 24
144
Notice of proposed sale of securities
14 Mar 24
4
Fabio Sandri
7 Mar 24
4
Matthew R Galvanoni
7 Mar 24
3
Filho Wesley Mendonca Batista
5 May 23
4
Karoleski Joanita Maria Maestri
28 Apr 23
4
Arquimedes Celis
28 Apr 23
4
Raul Padilla
28 Apr 23
4
wallim cruz de vasconcellos jr
28 Apr 23
4
Farha Aslam
28 Apr 23